

Targeting RAS-Addicted PDAC | Learn About RAS Mutations
SponsoredCurrently available treatments fall short in treating patients with RAS-addicted PDAC. Given its pivotal role in PDAC, RAS has strong potential to be a therapeutic target.Learn About NF1 PN Treatment | Official Physician Website
SponsoredIndicated for NF1 patients aged 2-18 with symptomatic, inoperable plexiform neurofibromas. Visit the HCP site to learn about an FDA-approved treatment as an option for your patientsMetastatic Solid Tumor Therapy | Data For Different Tumor Types
SponsoredApproved Therapy For Certain People With Metastatic HER2+ Solid Tumors. Patient Site. Explore Data & Results In Different Tumor Types For A Treatment Option.